Can tailored exercise help young sarcoma survivors recover strength?

NCT ID NCT07662239

Not yet recruiting Symptom relief Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a personalized exercise program can improve physical function and quality of life in adolescents and young adults who have survived sarcoma. Participants first complete a triage tool to assess their needs, then receive a 12-week exercise plan that may include supervised or home-based activities with tools like resistance bands and a stepper. The goal is to see if this approach is feasible and helps survivors move better and feel healthier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: personalized exercise program
What this could lead to: If successful, this approach could help young sarcoma survivors regain strength and mobility after treatment.
What could go wrong: This is a small pilot study, so results may not apply to all survivors. The exercise program may be too demanding for some participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone cancer bone sarcoma sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE SARCOMA SARCOMA SOFT TISSUE SARCOMA (STS)

Contacts and locations

Locations

Boston Children's Hospital

Boston, Massachusetts, 02115, United States
Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States
Dana-Farber Cancer Institute

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.